Across TCGA pan-cancer cohorts, DCAF12L1 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of DCAF12L1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where DCAF12L1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types DCAF12L1 is over-expressed in tumor, although a few such as COAD and OV show the opposite, repressed pattern.
COAD, OV, and LUAD are the cancer types where DCAF12L1 tumor–normal differential expression is most reproducible.